Eli Lilly's Solanezumab Failure: Alzheimer's Treatment Space Feels Aftershock By: Benzinga via Benzinga November 23, 2016 at 13:22 PM EST After Eli Lilly and Co (NYSE: LLY) earlier announce the failure of its Alzeheimer’s candidate solanezumab, the entire ... Read More >> Related Stocks: AC Immune S.A. Alkermes Plc Allergan Plc Anavex Lf SC Biogen Idec Eli Lilly Novartis Ag ADR Roche Holding AG Basel American Depositary Shares